Phase 2
๐ Investigational Drug / Biologic
NCT07015242
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
๐ University Of Colorado โ Aurora, Colorado
View Study & Screener โ